Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: a randomized, multicenter phase III trial.
暂无分享，去创建一个
D. Mavroudis | V. Georgoulias | I. Boukovinas | K. Syrigos | A. Polyzos | I. Varthalitis | A. Kotsakis | V. Chandrinos | L. Vamvakas | N. Androulakis | D. Hatzidaki | M. Agelidou | A. Agelidou | N. Ziras | A. Geroyianni